Mechanisms of acrolein-induced myocardial dysfunction: implications for environmental and endogenous aldehyde exposure

Abstract

Aldehydes are ubiquitous pollutants generated during the combustion of organic materials and are present in air, water, and food. Several aldehydes are also endogenous products of lipid peroxidation and by-products of drug metabolism. Despite well-documented high reactivity of unsaturated aldehydes, little is known regarding their cardiovascular effects and their role in cardiac pathology. Accordingly, we examined the myocardial effects of the model unsaturated aldehyde acrolein. In closed-chest mice, intravenous acrolein (0.5 mg/kg) induced rapid but reversible left ventricular dilatation and dysfunction. In mouse myocytes, micromolar acrolein acutely depressed myofilament Ca(2+) responsiveness without altering catecholamine sensitivity, similar to the phenotype of stunned myocardium. Immunoblotting revealed increased acrolein-protein adducts and protein-carbonyls in both acrolein-exposed myocardium (1.8-fold increase, P < 0.002) and myocytes (6.4-fold increase, P < 0.02). Both the contractile dysfunction and adduct formation were markedly attenuated by pretreatment with the thiol donor N-acetylcysteine (5 mM). Two-dimensional gel electrophoresis and mass-assisted laser desorption/ionization time-of-flight mass spectrometry analysis revealed two groups of adducted proteins, sarcomeric/cytoskeletal proteins (cardiac alpha-actin, desmin, myosin light polypeptide 3) and energy metabolism proteins (mitochondrial creatine kinase-2, ATP synthase), indicating site-specific protein modification that was confirmed by immunohistochemical colocalization. We conclude that direct exposure to acrolein induces selective myofilament impairment, which may be, in part, related to the modification of proteins involved in myocardial contraction and energy metabolism. Myocardial dysfunction induced by acrolein and related aldehydes may be symptomatic of toxicological states associated with ambient or occupational exposures or drug toxicity. Moreover, aldehydes such as acrolein may mediate cardiac dysfunction in pathologies characterized by high-oxidative stress.

Hemin causes mitochondrial dysfunction in endothelial cells through promoting lipid peroxidation: the protective role of autophagy

“…Lipid peroxidation products such as HNE and isoprostanes have been shown to affect mitochondrial function (26,27,30,34,38,40,44). We have previously used biotinylated lipids to monitor protein adduct formation with reactive lipid species in cells (14,25,61).…”

Fibroblast growth factor 21 protects the heart from apoptosis in a diabetic mouse model via extracellular signal-regulated kinase 1/2-dependent signalling pathway

“…Primary cardiomyocyte isolation, cell culture, palmitate and FGF21 treatments and small interfering RNA transfection Adult mouse cardiomyocytes were isolated as described previously [24]. H9c2 cells and/or cardiomyocytes were pre-treated with pharmaceutical inhibitors or specific small interfering (si)RNAs against Erk1 (also known as Mapk3)/Erk2 (also known as Mapk1), p38Mapk (also known as Mapk14) and Ampk with or without FGF21 (50 ng/ml), followed by palmitate treatment for 15 h. A pilot time-course study has been performed to optimise the transfection efficiency with p38Mapk siRNA in adult mouse cardiomyocytes (ESM Fig.…”

Standardized bioenergetic profiling of adult mouse cardiomyocytes

“…Primary ACMs were isolated from 8 to 12 wk old male, wild-type C57BL/6 mice (n ϭ 15) by the Langendorff perfusion method as previously described (12,13,17,29). In brief, mice were anesthetized with 5% isoflurane, and the heart was rapidly excised and placed in ice-cold PBS for 2 min.…”